Association of the HLA DQA1*05 allelic gene variants with immunogenicity to anti-TNF therapeutics - important differences between infliximab and adalimumab

Nicola Ternette; Hanqing Liao; Jack Satsangi

doi:10.1093/ecco-jcc/jjae172

Association of the HLA DQA1*05 allelic gene variants with immunogenicity to anti-TNF therapeutics - important differences between infliximab and adalimumab

Nicola Ternette (Lead / Corresponding author)
, Hanqing Liao
, Jack Satsangi (Lead / Corresponding author)

Cell Signalling and Immunology

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

87 Downloads (Pure)

Original language	English
Article number	jjae172
Number of pages	2
Journal	Journal of Crohn's and Colitis
Volume	19
Issue number	4
Early online date	16 Nov 2024
DOIs	https://doi.org/10.1093/ecco-jcc/jjae172
Publication status	Published - Apr 2025

ASJC Scopus subject areas

General Medicine

Access to Document

10.1093/ecco-jcc/jjae172Licence: CC BY

Final published versionFinal published version, 178 KBLicence: CC BY

Cite this

@article{b32d453fa7864daf9272faa7689a81a7,

title = "Association of the HLA DQA1*05 allelic gene variants with immunogenicity to anti-TNF therapeutics - important differences between infliximab and adalimumab",

author = "Nicola Ternette and Hanqing Liao and Jack Satsangi",

year = "2025",

month = apr,

doi = "10.1093/ecco-jcc/jjae172",

language = "English",

volume = "19",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

number = "4",

}

Association of the HLA DQA1*05 allelic gene variants with immunogenicity to anti-TNF therapeutics - important differences between infliximab and adalimumab. / Ternette, Nicola (Lead / Corresponding author); Liao, Hanqing; Satsangi, Jack (Lead / Corresponding author).
In: Journal of Crohn's and Colitis, Vol. 19, No. 4, jjae172, 04.2025.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Association of the HLA DQA1*05 allelic gene variants with immunogenicity to anti-TNF therapeutics - important differences between infliximab and adalimumab

AU - Ternette, Nicola

AU - Liao, Hanqing

AU - Satsangi, Jack

PY - 2025/4

Y1 - 2025/4

UR - https://www.scopus.com/pages/publications/105002817552

U2 - 10.1093/ecco-jcc/jjae172

DO - 10.1093/ecco-jcc/jjae172

M3 - Letter

C2 - 39548751

SN - 1873-9946

VL - 19

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

IS - 4

M1 - jjae172

ER -

Association of the HLA DQA1*05 allelic gene variants with immunogenicity to anti-TNF therapeutics - important differences between infliximab and adalimumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this